| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/S41409-018-0301-7 |
| P698 | PubMed publication ID | 30108330 |
| P50 | author | Kazuhiko Kakihana | Q59827963 |
| Shohei Mizuno | Q85029662 | ||
| P2093 | author name string | Heiwa Kanamori | |
| Takahiro Fukuda | |||
| Yoshiko Atsuta | |||
| Tetsuo Maeda | |||
| Hirohisa Nakamae | |||
| Koji Iwato | |||
| Yoshinobu Kanda | |||
| Yukiyasu Ozawa | |||
| Tetsuya Eto | |||
| Shuichi Ota | |||
| Takehiko Mori | |||
| Jun Aoki | |||
| Tatsuo Ichinohe | |||
| Junji Tanaka | |||
| Masamitsu Yanada | |||
| Shingo Yano | |||
| Jinichi Mori | |||
| Masayoshi Masuko | |||
| Souichi Shiratori | |||
| P2860 | cites work | Defining the intensity of conditioning regimens: working definitions | Q24630836 |
| Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data). | Q31019536 | ||
| Scripts for TRUMP data analyses. Part II (HLA-related data): statistical analyses specific for hematopoietic stem cell transplantation | Q31026869 | ||
| The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors | Q34128401 | ||
| Reduced mortality after allogeneic hematopoietic-cell transplantation | Q34472861 | ||
| Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made? | Q34743469 | ||
| Significant improvement in survival after unrelated donor hematopoietic cell transplantation in the recent era | Q34749365 | ||
| Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors | Q36951734 | ||
| Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns | Q37811681 | ||
| Allogeneic hematopoietic cell transplantation for acute myeloid leukemia during first complete remission: a clinical perspective | Q38248427 | ||
| Effect of cytogenetic risk status on outcomes for patients with acute myeloid leukemia undergoing various types of allogeneic hematopoietic cell transplantation: an analysis of 7812 patients. | Q38657161 | ||
| Hematopoietic stem cell transplantation for patients with AML in first complete remission | Q38667488 | ||
| Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes | Q38852431 | ||
| Alloreactivity: the Janus-face of hematopoietic stem cell transplantation | Q38922235 | ||
| Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for younger patients with acute myeloid leukemia: a registry-based study | Q39005630 | ||
| Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial. | Q40475236 | ||
| Changes in incidence and causes of non-relapse mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia/myelodysplastic syndrome: an analysis of the Japan Transplant Outcome Registry. | Q44706384 | ||
| Increased activity and improved outcome in unrelated donor haemopoietic cell transplants for acute myeloid leukaemia in Australia, 1992-2005. | Q45808982 | ||
| Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial. | Q53787349 | ||
| Improved Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Recent Years. A Single-Center Study | Q58789014 | ||
| Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor program. | Q64988288 | ||
| Improved outcome in young adults with de novo acute myeloid leukemia in first remission, undergoing an allogeneic bone marrow transplant | Q80521873 | ||
| Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers. Better results in recent years | Q83508614 | ||
| Impact of a single human leucocyte antigen (HLA) allele mismatch on the outcome of unrelated bone marrow transplantation over two time periods. A retrospective analysis of 3003 patients from the HLA Working Group of the Japan Society for Blood and M | Q86242931 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| acute myeloid leukemia | Q264118 | ||
| P304 | page(s) | 578-586 | |
| P577 | publication date | 2018-08-14 | |
| P1433 | published in | Bone Marrow Transplantation | Q4941523 |
| P1476 | title | Patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: trends in survival during the past two decades | |
| P478 | volume | 54 |
| Q90590385 | Long-term results of reduced-intensity conditioning allogeneic hematopoietic cell transplantation for older patients with acute myeloid leukemia: a retrospective analysis of 10-year follow-up data | cites work | P2860 |
Search more.